Products

At the end of 2018, Virbac launched an online campaign in North America encouraging owners to consult their veterinarian about their dog’s dental health. It included a humorous video broadcasted on social networks, featuring a rubber toy that hates being chewed by a dog with bad breath.

In August, the FDA approved the transfer of production to the Virbac St. Louis site (Missouri) of a parasiticide for dogs acquired by the company at the beginning of 2015. The complexity of the industrial extrusion process required all the skills and attention of the American subsidiary and the Group's Production/Quality teams for nearly three years.

Bad breath is a common complaint of dogs’ owners but it can also be a sign of periodontal or digestive issues that can be painful for the pet. Thanks to a new formula, the C.E.T^® VEGGIEDENT^® FR3SH^™ dental chews tackle the oral causes of bad breath and help to restore the animal's intestinal balance while freshening its breath. Available since 2018 in the United States, Canada, the United Kingdom, France, Spain and Japan, they will gradually be present around the world in 2019.

One of the present challenges of swine producers is finding solutions that preserve farm productivity while reducing the use of antibiotics. In Europe, Latin America and Asia, Virbac is assisting veterinarians and farmers with technical solutions and on farm training that focus on prevention and are based on a good reproduction management.

Since 2017, Virbac has been offering veterinarians Speed Reader^TM, a blood marker dosage analyzer with a series of biomarker tests. Usable directly in-clinic, these newest additions to the diagnostic range facilitate screening of common diseases in cats and dogs and ensure better monitoring of the animal.

Maintaining good health and welfare of cows is central to Virbac's approach of dairy production. Virbac created a specific program for professionals of dairy farming called Target 150. This program aims at bringing global & integrated solutions and protocols for a better and more sustainable production of milk. Developed in close cooperation with worldwide known experts, Target 150 ™ encourages prevention and answers the main problematics of the 150 critical days of production cycle of the dairy cows. As an essential part of the program, the second Virbac Dairy Symposium was organized in September 2017 to contribute strengthening the skills of dairy farming professionals and prepare them to the emerging technologies of tomorrow.

Two years after its launch, with a rating of 17.5/20, the VETERINARY HPM^® Adult with salmon neutered & entire cat is one of the ‘best choices’ amongst thirteen dry cat foods (kibbles) tested by the INC (Institut National de la Consommation [French National Institute for Consumer Affairs]). This rating makes up for several years of development.

The treatment of dogs infected with leishmaniosis has been authorized in Brazil since 2016. Thanks to its publicity campaigns and its treatment solution introduced in January 2017, Virbac is contributing to the fight against this disease which, on a world scale, touches about 1 million of humans. 

VETERINARY HPM™ dietetic is a new generation of nutrition for cats and dogs with health problems, created by staying close to the nutritional requirements of carnivores, respecting the nutritional requirements of carnivores. These foods should be recommended by the veterinarian depending on the animal's health problem. A veterinarian's option should be sought before use. Available since spring 2017 in European veterinary clinics, the VETERINARY HPM™ dietetic range will also be launched in Latin America (Mexico, Costa Rica and Chile) by the end of the year.

Whether in the meat or dairy industries, quality production requires animals that are healthy from birth onward! With this in mind, Virbac has been progressively rolling out a complete Calf health management program in Europe since 2016. 

In May 2016, European practitioners (France, UK and Austria) discovered Effipro^® Duo, a new parasiticide used to treat and prevent tick and flea infestations in dogs and cats. The advantages of this product described by the Global Marketing manager parasiticides.

Following the launch of the VETERINARY HPM™ physiological range in 2015, Virbac started from March 1^st the launch of VETERINARY HPM™ dietetic for dogs and cats in Europe. A complete range still close to the nutritional requirements of carnivores and associated to the "Veterinary global care", a new global nutritional approach.

The product VETERINARY HPM^® Adult Small & Toy has received a rating of 16.4/20 from the independent French consumer association UFC-Que Choisir. The cited product has been qualified as one of the “best choices” amongst the twenty complete dog foods that were tested. 

Since 2012, Virbac has maintained a presence in China through a commercial subsidiary that now has about thirty collaborators. How is the subsidiary adapting to this ever-changing market? Answers by the subsidiary general manager.

On March 8, 2016, Virbac US announced the launch of the latest advancement in canine joint health supplementation, MOVOFLEX™ Soft Chews. Formulated with a unique and proprietary blend of ingredients, MOVOFLEX™ Soft Chews provide comprehensive canine joint support in a once-a-day palatable soft chew.

On March 1, 2016, Virbac US announced the launch of the C.E.T.^® OraStrip^® Dental Diagnostic Test (currently distributed in the USA), the first and only test in the animal health market that detects periodontal infection in dogs, providing visual test results to support veterinarians’ dental treatment recommendations and enhance client compliance.

Virbac has been distributing the parasiticide medicines Activyl^® and Activyl^® Tick Plus in Europe since January 1, 2016. The integration of these two medicines in the parasiticide product portfolio fulfils Virbac’s wish to offer complementary solutions to veterinarians.

Virbac commercializes a new hyper premium nutritional concept for dogs and cats! 

26%. This is 2014 Virbac Colombia's market share on the dog and cat vaccines segment. This figure is evidence of the success that the subsidiary has met with in this fast-growing sector. The story of a lightningfast journey by colombian Marketing manager.

New premises, dairy crisis, market concentration... 2015 is marking a turning point for the subsidiary in New Zealand. How are such evolutions to be tackled? Answers from general manager of the subsidiary.

November 2014, London. For its use of augmented reality technology Virbac UK is awarded the Best Large Stand award for the most innovative stand. Just a gadget or a genuine opportunity for improved communication? Some answers from the companion animal business unit director of the subsidiary.

April 2014, Moscow. At Russia's largest veterinary congress, Virbac launched Cortavance, a corticoid for the treatment of inflammatory dermatosis in dogs. A major step forward for the companion animal portfolio in this country. Explanations by the Rest of Europe product manager.

In 2014, the innovative Flexibag^® and Farmpack^® products from Virbac were awarded three prizes: the 'Janus de la Santé' award for an environmentally-friendly design, the Pharmapack award and a "Sommet d’Or" award. In Flexibag^® and Farmpack^®, Virbac offer the first truly successful ergonomic design for simplified anti-parasite treatment of cattle and sheep, one which also improves productivity in the stock-rearing sector.

France, Germany, Switzerland, Portugal, Austria, United Kingdom and Scandinavia. These were the first European countries to launch Pronefra in the first half of 2014. A presentation of this food supplement by the global marketing manager supportive care & topical hygiene.

Viva VIVID! summer 2013, Virbac Australia opened a new R&D centre in Penrith surrounded by those involved in the local animal health industry. A key event for the development of the subsidiary’s biological activity in food producing animals. Explanations by Robert Dempster, the local RDL manager.

May 2013, Prague. In partnership with the European Veterinary Dental Society, Virbac is launching the e.VDS, an application for evaluating animal dentition (scoring) and developing knowledge for veterinarians all over the world. A look at the tool’s functionalities and objectives with Alain Mondon, Global Marketing manager, companion animals parasiticides.

After Multimin in 2011, Virbac RSA finalized in 2012 the acquisition of the worldwide rights to Browse Plus, a nutritional supplement for food producing animals and leader on the South African market since 1994. This acquisition by Dayle Sinclair, product manager.

In summer 2012, Virbac Brazil launched Effipro, a fipronil-based external parasiticide for dogs and cats. After a year of marketing, sales are good. A look at this success with Daniela Baccarin, product manager.

The successful management of an outbreak of neonatal calf diarrhoea relies on the individual treatment of sick animals and the prevention of disease transmission. In this context, identification of the pathogens involved enables the vet to select the most appropriate treatment and prophylactic measures for each case.

Faithful to its strategy of continuous innovation, this year Virbac is launching the 1st mini polymeric transponder in Europe (France, Netherlands, Germany, Austria, Belgium), the BackHome^® Biotec Slim Transponder.

Rilexine and Suprelorin F: two products launched in the American market mid 2012 thanks to the hard work of the Virbac US R&D teams to adapt the registration dossiers. A look at the challenges with Craig Parks, R&D vice-president.

Since June 2012, Virbac France has offered a long-term treatment that aims to reduce inflammation and pain for dogs with acute and chronic musculoskeletal disorders. This medicine adds to Virbac's canine osteoarthritis range which now provides comprehensive care for canine osteoarthritis.

01/02/2010. Paris - France. Pharmapack award "Home risks prevention - veterinary category" has been awarded to Milteforan, the first veterinary medicinal product intended to treat the leishmaniasis and that can be administered by oral route. 

The fruit of several years of development, Effipro^® Spot On and Effipro^® Spray are two Fipronil-based medicines which treat flea and tick infestations in dogs and cats.